Skip to content

Contact +44 (0) 20 7060 7474 email us

Generic Drugs

Generics

Global Industry Guide

Publication Date November 2008
Publisher Datamonitor
Product Type Report
Pages 197
ISBN Number not applicable
Product Code DAT01018

Price

£790.00
approximately: $1,295 | €921

pdf

Buy Now

print £840 ($1,377 | €980)

Buy Now

Order above formats by FAX

Order by Fax

Summary

Datamonitor's Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
  • Includes a five-year forecast of the industry

Highlights

  • The global generics market grew by 12.3% in 2007 to reach a value of $108 billion.
  • In 2012, the market is forecast to have a value of $178 billion, an increase of 64.7% since 2007.
  • The ethical generic segment dominates the market with 76.1% share.
  • The Americas generate 40.1% of the global genericas market's value

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

  • The value of the generics market consists of all sales of generics drugs at ex-manufacturers prices. The market does not include animal healthcare products. Datamonitor defines a generic as a product, which is an officially approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name. This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at constant 2007 average exchange rates.
  • For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.
  • Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
  • Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.
  • The global figure comprises the Americas, Asia-Pacific and Europe.

Contents

  • Chapter 1 Introduction
    • 1.1 What is this report about?
    • 1.2 Who is the target reader?
    • 1.3 How to use this report
    • 1.4 Definitions
  • Chapter 2 Global Generics
    • 2.1 Market Overview
    • 2.2 Market Value
    • 2.3 Market Segmentation I
    • 2.4 Market Segmentation II
    • 2.5 Five Forces Analysis
    • 2.6 Market Forecasts
  • Chapter 3 Generics in Asia-Pacific
    • 3.1 Market Overview
    • 3.2 Market Value
    • 3.3 Market Segmentation I
    • 3.4 Market Segmentation II
    • 3.5 Five Forces Analysis
    • 3.6 Market Forecasts
  • Chapter 4 Generics in Europe
    • 4.1 Market Overview
    • 4.2 Market Value
    • 4.3 Market Segmentation I
    • 4.4 Market Segmentation II
    • 4.5 Five Forces Analysis
    • Market Forecasts
    • Market Forecasts
  • Chapter 5 Generics in Belgium
    • 5.1 Market Overview
    • 5.2 Market Value
    • 5.3 Market Segmentation I
    • 5.4 Market Segmentation II
    • 5.5 Five Forces Analysis
    • 5.6 Market Forecasts
  • Chapter 6 Generics in Canada
    • 6.1 Market Overview
    • 6.2 Market Value
    • 6.3 Market Segmentation I
    • 6.4 Market Segmentation II
    • 6.5 Five Forces Analysis
  • Chapter 7 Generics in China
    • 7.1 Market Overview
    • 7.2 Market Value
    • 7.3 Market Segmentation I
    • 7.4 Market Segmentation II
    • 7.5 Five Forces Analysis
    • 7.6 Market Forecasts
  • Chapter 8 Generics in France
    • 8.1 Market Overview
    • 8.2 Market Value
    • 8.3 Market Segmentation I
    • 8.4 Market Segmentation II
    • 8.5 Five Forces Analysis
    • 8.6 Market Forecasts
  • Chapter 9 Generics in Germany
    • 9.1 Market Overview
    • 9.2 Market Value
    • 9.3 Market Segmentation I
    • 9.4 Market Segmentation II
    • 9.5 Five Forces Analysis
    • 9.6 Market Forecasts
  • Chapter 10 Generics in Italy
    • 10.1 Market Overview
    • 10.2 Market Value
    • 10.3 Market Segmentation I
    • 10.4 Market Segmentation II
    • 10.5 Five Forces Analysis
  • Chapter 11 Generics in Japan
    • 11.1 Market Overview
    • 11.2 Market Value
    • 11.3 Market Segmentation I
    • 11.4 Market Segmentation II
    • 11.5 Five Forces Analysis
  • Chapter 12 Generics in The Netherlands
    • 12.1 Market Overview
    • 12.2 Market Value
    • 12.3 Market Segmentation I
    • 12.4 Market Segmentation II
    • 12.5 Five Forces Analysis
    • 12.6 Market Forecasts
  • Chapter 13 Generics in Spain
    • 13.1 Market Overview
    • 13.2 Market Value
    • 13.3 Market Segmentation I
    • 13.4 Market Segmentation II
    • 13.5 Five Forces Analysis
    • 13.6 Market Forecasts
  • Chapter 14 Generics in The United Kingdom
    • 14.1 Market Overview
    • 14.2 Market Value
    • 14.3 Market Segmentation I
    • 14.4 Market Segmentation II
    • 14.5 Five Forces Analysis
    • 14.6 Market Forecasts
  • Chapter 15 Generics in The United States
    • 15.1 Market Overview
    • 15.2 Market Value
    • 15.3 Market Segmentation I
    • 15.4 Market Segmentation II
    • 15.5 Five Forces Analysis
  • Chapter 16 Company Profiles
    • 16.1 Leading Companies
  • Chapter 17 Appendix
    • 17.1 Data Research Methodology
  • List of Tables
    • Table 1: Global Generics Market Value: $ billion, 2003-2007
    • Table 2: Global Generics Market Segmentation I: % Share, by Value, 2007
    • Table 3: Global Generics Market Segmentation II: % Share, by Value, 2007
    • Table 4: Global Generics Market Value Forecast: $ billion, 2007-2012
    • Table 5: Asia-Pacific Generics Market Value: $ billion, 2003-2007
    • Table 6: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2007
    • Table 7: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2007
    • Table 8: Asia-Pacific Generics Market Value Forecast: $ billion, 2007-2012
    • Table 9: Europe Generics Market Value: $ billion, 2003-2007
    • Table 10: Europe Generics Market Segmentation I: % Share, by Value, 2007
    • Table 11: Europe Generics Market Segmentation II: % Share, by Value, 2007
    • Table 12: Europe Generics Market Value Forecast: $ billion, 2007-2012
    • Table 13: Belgium Generics Market Value: $ million, 2003-2007
    • Table 14: Belgium Generics Market Segmentation I: % Share, by Value, 2007
    • Table 15: Belgium Generics Market Segmentation II: % Share, by Value, 2007
    • Table 16: Belgium Generics Market Value Forecast: $ million, 2007-2012
    • Table 17: Canada Generics Market Value: $ billion, 2003-2007
    • Table 18: Canada Generics Market Segmentation I: % Share, by Value, 2007
    • Table 19: Canada Generics Market Segmentation II: % Share, by Value, 2007
    • Table 20: Canada Generics Market Value Forecast: $ billion, 2007-2012
    • Table 21: China Generics Market Value: $ billion, 2003-2007
    • Table 22: China Generics Market Segmentation I: % Share, by Value, 2007
    • Table 23: China Generics Market Segmentation II: % Share, by Value, 2007
    • Table 24: China Generics Market Value Forecast: $ billion, 2007-2012
    • Table 25: France Generics Market Value: $ billion, 2003-2007
    • Table 26: France Generics Market Segmentation I: % Share, by Value, 2007
    • Table 27: France Generics Market Segmentation II: % Share, by Value, 2007
    • Table 28: France Generics Market Value Forecast: $ billion, 2007-2012
    • Table 29: Germany Generics Market Value: $ billion, 2003-2007
    • Table 30: Germany Generics Market Segmentation I: % Share, by Value, 2007
    • Table 31: Germany Generics Market Segmentation II: % Share, by Value, 2007
    • Table 32: Germany Generics Market Value Forecast: $ billion, 2007-2012
    • Table 33: Italy Generics Market Value: $ million, 2003-2007
    • Table 34: Italy Generics Market Segmentation I: % Share, by Value, 2007
    • Table 35: Italy Generics Market Segmentation II: % Share, by Value, 2007
    • Table 36: Italy Generics Market Value Forecast: $ million, 2007-2012
    • Table 37: Japan Generics Market Value: $ billion, 2003-2007
    • Table 38: Japan Generics Market Segmentation I: % Share, by Value, 2007
    • Table 39: Japan Generics Market Segmentation II: % Share, by Value, 2007
    • Table 40: Japan Generics Market Value Forecast: $ billion, 2007-2012
    • Table 41: Netherlands Generics Market Value: $ billion, 2003-2007
    • Table 42: Netherlands Generics Market Segmentation I: % Share, by Value, 2007
    • Table 43: Netherlands Generics Market Segmentation II: % Share, by Value, 2007
    • Table 44: Netherlands Generics Market Value Forecast: $ billion, 2007-2012
    • Table 45: Spain Generics Market Value: $ billion, 2003-2007
    • Table 46: Spain Generics Market Segmentation I: % Share, by Value, 2007
    • Table 47: Spain Generics Market Segmentation II: % Share, by Value, 2007
    • Table 48: Spain Generics Market Value Forecast: $ billion, 2007-2012
    • Table 49: United Kingdom Generics Market Value: $ billion, 2003-2007
    • Table 50: United Kingdom Generics Market Segmentation I: % Share, by Value, 2007
    • Table 51: United Kingdom Generics Market Segmentation II: % Share, by Value, 2007
    • Table 52: United Kingdom Generics Market Value Forecast: $ billion, 2007-2012
    • Table 53: United States Generics Market Value: $ billion, 2003-2007
    • Table 54: United States Generics Market Segmentation I: % Share, by Value, 2007
    • Table 55: United States Generics Market Segmentation II: % Share, by Value, 2007
    • Table 56: United States Generics Market Value Forecast: $ billion, 2007-2012
    • Table 57: Key Facts: Teva Pharmaceutical Industries
    • Table 58: Key Financials: Teva Pharmaceutical Industries
    • Table 59: Key Facts: Sandoz GmbH
    • Table 60: Key Facts: Merck KGaA
    • Table 61: Key Financials: Merck KGaA
  • List of Figures
    • Figure 1: Global Generics Market Value: $ billion, 2003-2007
    • Figure 2: Global Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 3: Global Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 4: Forces Driving Competition in the Generics Market in Global, 2007
    • Figure 5: Drivers of Buyer Power in the Generics Market in Global, 2007
    • Figure 6: Drivers of Supplier Power in the Generics Market in Global, 2007
    • Figure 7: Factors Influencing the Likelihood of New Entrants in the Generics Market in Global, 2007
    • Figure 8: Factors Influencing the Threat of Substitutes in the Generics Market in Global, 2007
    • Figure 9: Drivers of Degree of Rivalry in the Generics Market in Global, 2007
    • Figure 10: Global Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 11: Asia-Pacific Generics Market Value: $ billion, 2003-2007
    • Figure 12: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 13: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 14: Forces Driving Competition in the Generics Market in Asia-Pacific, 2007
    • Figure 15: Drivers of Buyer Power in the Generics Market in Asia-Pacific, 2007
    • Figure 16: Drivers of Supplier Power in the Generics Market in Asia-Pacific, 2007
    • Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Asia-Pacific, 2007
    • Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Asia-Pacific, 2007
    • Figure 19: Drivers of Degree of Rivalry in the Generics Market in Asia-Pacific, 2007
    • Figure 20: Asia-Pacific Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 21: Europe Generics Market Value: $ billion, 2003-2007
    • Figure 22: Europe Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 23: Europe Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 24: Forces Driving Competition in the Generics Market in Europe, 2007
    • Figure 25: Drivers of Buyer Power in the Generics Market in Europe, 2007
    • Figure 26: Drivers of Supplier Power in the Generics Market in Europe, 2007
    • Figure 27: Factors Influencing the Likelihood of New Entrants in the Generics Market in Europe, 2007
    • Figure 28: Factors Influencing the Threat of Substitutes in the Generics Market in Europe, 2007
    • Figure 29: Drivers of Degree of Rivalry in the Generics Market in Europe, 2007
    • Figure 30: Europe Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 31: Belgium Generics Market Value: $ million, 2003-2007
    • Figure 32: Belgium Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 33: Belgium Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 34: Forces Driving Competition in the Generics Market in Belgium, 2007
    • Figure 35: Drivers of Buyer Power in the Generics Market in Belgium, 2007
    • Figure 36: Drivers of Supplier Power in the Generics Market in Belgium, 2007
    • Figure 37: Factors Influencing the Likelihood of New Entrants in the Generics Market in Belgium, 2007
    • Figure 38: Factors Influencing the Threat of Substitutes in the Generics Market in Belgium, 2007
    • Figure 39: Drivers of Degree of Rivalry in the Generics Market in Belgium, 2007
    • Figure 40: Belgium Generics Market Value Forecast: $ million, 2007-2012
    • Figure 41: Canada Generics Market Value: $ billion, 2003-2007
    • Figure 42: Canada Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 43: Canada Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 44: Forces Driving Competition in the Generics Market in Canada, 2007
    • Figure 45: Drivers of Buyer Power in the Generics Market in Canada, 2007
    • Figure 46: Drivers of Supplier Power in the Generics Market in Canada, 2007
    • Figure 47: Factors Influencing the Likelihood of New Entrants in the Generics Market in Canada, 2007
    • Figure 48: Factors Influencing the Threat of Substitutes in the Generics Market in Canada, 2007
    • Figure 49: Drivers of Degree of Rivalry in the Generics Market in Canada, 2007
    • Figure 50: Canada Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 51: China Generics Market Value: $ billion, 2003-2007
    • Figure 52: China Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 53: China Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 54: Forces Driving Competition in the Generics Market in China, 2007
    • Figure 55: Drivers of Buyer Power in the Generics Market in China, 2007
    • Figure 56: Drivers of Supplier Power in the Generics Market in China, 2007
    • Figure 57: Factors Influencing the Likelihood of New Entrants in the Generics Market in China, 2007
    • Figure 58: Factors Influencing the Threat of Substitutes in the Generics Market in China, 2007
    • Figure 59: Drivers of Degree of Rivalry in the Generics Market in China, 2007
    • Figure 60: China Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 61: France Generics Market Value: $ billion, 2003-2007
    • Figure 62: France Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 63: France Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 64: Forces Driving Competition in the Generics Market in France, 2007
    • Figure 65: Drivers of Buyer Power in the Generics Market in France, 2007
    • Figure 66: Drivers of Supplier Power in the Generics Market in France, 2007
    • Figure 67: Factors Influencing the Likelihood of New Entrants in the Generics Market in France, 2007
    • Figure 68: Factors Influencing the Threat of Substitutes in the Generics Market in France, 2007
    • Figure 69: Drivers of Degree of Rivalry in the Generics Market in France, 2007
    • Figure 70: France Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 71: Germany Generics Market Value: $ billion, 2003-2007
    • Figure 72: Germany Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 73: Germany Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 74: Forces Driving Competition in the the Generics Market in Germany, 2007
    • Figure 75: Drivers of Buyer Power in the the Generics Market in Germany, 2007
    • Figure 76: Drivers of Supplier Power in the the Generics Market in Germany, 2007
    • Figure 77: Factors Influencing the Likelihood of New Entrants in the the Generics Market in Germany, 2007
    • Figure 78: Factors Influencing the Threat of Substitutes in the the Generics Market in Germany, 2007
    • Figure 79: Drivers of Degree of Rivalry in the Generics Market in Germany, 2007
    • Figure 80: Germany Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 81: Italy Generics Market Value: $ million, 2003-2007
    • Figure 82: Italy Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 83: Italy Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 84: Forces Driving Competition in the Generics Market in Italy, 2007
    • Figure 85: Drivers of Buyer Power in the Generics Market in Italy, 2007
    • Figure 86: Drivers of Supplier Power in the Generics Market in Italy, 2007
    • Figure 87: Factors Influencing the Likelihood of New Entrants in the Generics Market in Italy, 2007
    • Figure 88: Factors Influencing the Threat of Substitutes in the Generics Market in Italy, 2007
    • Figure 89: Drivers of Degree of Rivalry in the Generics Market in Italy, 2007
    • Figure 90: Italy Generics Market Value Forecast: $ million, 2007-2012
    • Figure 91: Japan Generics Market Value: $ billion, 2003-2007
    • Figure 92: Japan Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 93: Japan Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 94: Forces Driving Competition in the Generics Market in Japan, 2007
    • Figure 95: Drivers of Buyer Power in the Generics Market in Japan, 2007
    • Figure 96: Drivers of Supplier Power in the Generics Market in Japan, 2007
    • Figure 97: Factors Influencing the Likelihood of New Entrants in the Generics Market in Japan, 2007
    • Figure 98: Factors Influencing the Threat of Substitutes in the Generics Market in Japan, 2007
    • Figure 99: Drivers of Degree of Rivalry in the Generics Market in Japan, 2007
    • Figure 100: Japan Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 101: Netherlands Generics Market Value: $ billion, 2003-2007
    • Figure 102: Netherlands Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 103: Netherlands Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 104: Forces Driving Competition in the Generics Market in the Netherlands, 2007
    • Figure 105: Drivers of Buyer Power in the Generics Market in the Netherlands, 2007
    • Figure 106: Drivers of Supplier Power in the Generics Market in the Netherlands, 2007
    • Figure 107: Factors Influencing the Likelihood of New Entrants in the Generics Market in the Netherlands, 2007
    • Figure 108: Factors Influencing the Threat of Substitutes in the Generics Market in the Netherlands, 2007
    • Figure 109: Drivers of Degree of Rivalry in the Generics Market in the Netherlands, 2007
    • Figure 110: Netherlands Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 111: Spain Generics Market Value: $ billion, 2003-2007
    • Figure 112: Spain Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 113: Spain Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 114: Forces Driving Competition in the Generics Market in Spain, 2007
    • Figure 115: Drivers of Buyer Power in the Generics Market in Spain, 2007
    • Figure 116: Drivers of Supplier Power in the Generics Market in Spain, 2007
    • Figure 117: Factors Influencing the Likelihood of New Entrants in the Generics Market in Spain, 2007
    • Figure 118: Factors Influencing the Threat of Substitutes in the Generics Market in Spain, 2007
    • Figure 119: Drivers of Degree of Rivalry in the Generics Market in Spain, 2007
    • Figure 120: Spain Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 121: United Kingdom Generics Market Value: $ billion, 2003-2007
    • Figure 122: United Kingdom Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 123: United Kingdom Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 124: Forces Driving Competition in the Generics Market in the UK, 2007
    • Figure 125: Drivers of Buyer Power in the Generics Market in the UK, 2007
    • Figure 126: Drivers of Supplier Power in the Generics Market in the UK, 2007
    • Figure 127: Factors Influencing the Likelihood of New Entrants in the Generics Market in the UK, 2007
    • Figure 128: Factors Influencing the Threat of Substitutes in the Generics Market in the UK, 2007
    • Figure 129: Drivers of Degree of Rivalry in the Generics Market in the UK, 2007
    • Figure 130: United Kingdom Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 131: United States Generics Market Value: $ billion, 2003-2007
    • Figure 132: United States Generics Market Segmentation I: % Share, by Value, 2007
    • Figure 133: United States Generics Market Segmentation II: % Share, by Value, 2007
    • Figure 134: Forces Driving Competition in the Generics Market in the United States, 2007
    • Figure 135: Drivers of Buyer Power in the Generics Market in the United States, 2007
    • Figure 136: Drivers of Supplier Power in the Generics Market in the United States, 2007
    • Figure 137: Factors Influencing the Likelihood of New Entrants in the Generics Market in the United States, 2007
    • Figure 138: Factors Influencing the Threat of Substitutes in the Generics Market in the United States, 2007
    • Figure 139: Drivers of Degree of Rivalry in the Generics Market in the United States, 2007
    • Figure 140: United States Generics Market Value Forecast: $ billion, 2007-2012
    • Figure 141: Revenues & Profitability: Teva Pharmaceutical Industries
    • Figure 142: Revenues & Profitability: Merck KGaA